Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9-10
pubmed:dateCreated
2006-10-2
pubmed:databankReference
pubmed:abstractText
Mitochondrial Complex II (succinate:ubiquinone oxidoreductase) is purified in a partially inactivated state, which can be activated by removal of tightly bound oxaloacetate (E.B. Kearney, et al., Biochem. Biophys. Res. Commun. 49 1115-1121). We crystallized Complex II in the presence of oxaloacetate or with the endogenous inhibitor bound. The structure showed a ligand essentially identical to the "malate-like intermediate" found in Shewanella Flavocytochrome c crystallized with fumarate (P. Taylor, et al., Nat. Struct. Biol. 6 1108-1112) Crystallization of Complex II in the presence of excess fumarate also gave the malate-like intermediate or a mixture of that and fumarate at the active site. In order to more conveniently monitor the occupation state of the dicarboxylate site, we are developing a library of UV/Vis spectral effects induced by binding different ligands to the site. Treatment with fumarate results in rapid development of the fumarate difference spectrum and then a very slow conversion into a species spectrally similar to the OAA-liganded complex. Complex II is known to be capable of oxidizing malate to the enol form of oxaloacetate (Y.O. Belikova, et al., Biochim. Biophys. Acta 936 1-9). The observations above suggest it may also be capable of interconverting fumarate and malate. It may be useful for understanding the mechanism and regulation of the enzyme to identify the malate-like intermediate and its pathway of formation from oxaloacetate or fumarate.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-10373108, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-10581550, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-10581551, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-10586875, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-10648801, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-11248702, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-12560550, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-13491588, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-15109257, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-15805592, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-15989954, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-16371358, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-2902878, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-4326880, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-4362058, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-4674478, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-4818821, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-5862429, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-6691982, http://linkedlifedata.com/resource/pubmed/commentcorrection/16935256-8325393
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0006-3002
pubmed:author
pubmed:issnType
Print
pubmed:volume
1757
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1073-83
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:articleTitle
Crystallographic studies of the binding of ligands to the dicarboxylate site of Complex II, and the identity of the ligand in the "oxaloacetate-inhibited" state.
pubmed:affiliation
Physical Biosciences Division, Lawrence Berkeley National Lab., MS 64-0121, 1 Cyclotron Road, Berkeley CA 94720, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural